Bacteria under SOS evolve anticancer phenotypes

Infectious Agents and Cancer

Volumn 5, Issue 1, 2010, Pages

  Dallo, Shatha F ^a   Weitao, Tao ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CANCER CELL; CANCER CONTROL; CANCER INVASION; DNA REPAIR; DNA REPLICATION; GENE EXPRESSION; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA;

EID: 77749298131     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-5-3     Document Type: Article

References (26)

1. The treatment of malignant tumours by repeated inoculations of erysipelas. With a report of ten original cases. 1893. WB Coley, Clin Orthop Relat Res 1991 262 3 11
2. The treatment of malignant tumours by bacterial toxins as developed by the late William B. Coley, MD, reviewed in the light of modern research. HC Nauts WE Swift BL Coley, Cancer Res 1946 6 205 216
3. Microorganisms and Cancer: Quest for a Therapy. AM Chakrabarty, J Bacteriol 2003 185 9 2683 2686
4. Use of bacteria as anticancer agents. KK Jain, Expert Opinion on Biological Therapy 2001 1 2 291 300
5. Multicellularity of a unicellular organism in response to DNA replication stress. T Weitao, Research in Microbiology 2009 160 1 87 88
6. Bacteria form biofilms against cancer metastasis. T Weitao, Medical Hypothesis 2009 72 4 477 478
7. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. GC Walker, Microbiol Mol Biol Rev 1984 48 1 60 93
8. Identification of additional genes belonging to the LexA regulon in Escherichia coli. AR Fernandez de Henestrosa T Ogi S Aoyagi D Chafin JJ Hayes H Ohmori R Woodgate, Molecular Microbiology 2000 35 6 1560 1572
9. Comparative Gene Expression Profiles Following UV Exposure in Wild-Type and SOS-Deficient Escherichia coli. J Courcelle A Khodursky B Peter PO Brown PC Hanawalt, Genetics 2001 158 1 41 64
10. Over 1000 genes are involved in the DNA damage response of Escherichia coli. PP Khil RD Camerini-Otero, Molecular Microbiology 2002 44 1 89 105
11. Defining the Pseudomonas aeruginosa SOS Response and Its Role in the Global Response to the Antibiotic Ciprofloxacin. RT Cirz BM O'Neill JA Hammond SR Head FE Romesberg, J Bacteriol 2006 188 20 7101 7110
12. Nature of the SOS-inducing signal in Escherichia coli: The involvement of DNA replication. M Sassanfar JW Roberts, Journal of Molecular Biology 1990 212 1 79 96
13. Mechanism of specific LexA cleavage: autodigestion and the role of RecA coprotease. JW Little, Biochimie 1991 73 4 411 421
14. A broadening view of recombinational DNA repair in bacteria. MM Cox, Genes to Cells 1998 3 2 65 78
15. Bacterial Chromosome Dynamics. DJ Sherratt, Science 2003 301 5634 780 785
16. Structural Analysis of the umu Operon Required for Inducible Mutagenesis in Escherichia coli. Y Kitagawa E Akaboshi H Shinagawa T Horii H Ogawa T Kato, Proceedings of the National Academy of Sciences 1985 82 13 4336 4340
17. Mutagenic Repair in Escherichia coli: Products of the recA Gene and of the umuD and umuC Genes Act at Different Steps in UV-Induced Mutagenesis. BA Bridges R Woodgate, Proceedings of the National Academy of Sciences 1985 82 12 4193 4197
18. A549 Lung Epithelial Cells Grown as Three-Dimensional Aggregates: Alternative Tissue Culture Model for Pseudomonas aeruginosa Pathogenesis. AJ Carterson K Honer zu Bentrup CM Ott MS Clarke DL Pierson CR Vanderburg KL Buchanan CA Nickerson MJ Schurr, Infect Immun 2005 73 2 1129 1140
19. Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy. M Mahfouz W Hashimoto TK Das Gupta AM Chakrabarty, Plasmid 2007 57 1 4 17
20. Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. T Yamada AM Fialho V Punj L Bratescu TKD Gupta AM Chakrabarty, Cellular Microbiology 2005 7 10 1418 1431
21. Bacterial proteins as potential drugs in the treatment of leukemia. JM Kwan AM Fialho M Kundu J Thomas CS Hong TK Das Gupta AM Chakrabarty, Leuk Res 2009 33 10 1392 1399
22. Pseudomonas aeruginosa under DNA replication inhibition tends to form biofilms via Arr. H Gotoh Y Zhang SF Dallo S Hong N Kasaraneni T Weitao, Research in Microbiology 2008 159 4 294 302
23. Ribonucleotide Reductase Inhibitors and Future Drug Design. J Shao B Zhou Chu Bernard Y Yen, Current Cancer Drug Targets 6 5 409 431
24. DNA Polymerases as Therapeutic Targets. AJ Berdis, Biochemistry 2008 47 32 8253 8260
25. DNA helicases as targets for anti-cancer drugs. S Sharma KM Doherty RM Brosh Jr, Curr Med Chem Anticancer Agents 2005 5 3 183 199
26. Next generation topoisomerase I inhibitors: Rationale and biomarker strategies. BA Teicher, Biochemical Pharmacology 2008 75 6 1262 1271